Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Open accessThe DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.
Abstract
In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public health threat. This article reviews their mechanisms of resistance, epidemiology, and clinical impact and current and upcoming therapeutic options. In vitro and in vivo treatment studies and pharmacokinetic and pharmacodynamic (PK/PD) models are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 1×
“Old in vitro and in vivo PK/PD studies initially defined an fT MIC of 40% as the optimal value for the bactericidal activity of carbapenems (235).”
BackgroundAntibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Tunkel, A. R., Hasbun, R., Bhimraj, A., Byers, K., Kaplan, S. L., Scheld, W. M., van de Beek, D., Bleck, T. P., Garton, H. J. L., & Zunt, J. R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw861 · Cited by 1,067
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Self-citationPaul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
Kang, C., Kim, S., Kim, H., Park, S., Choe, Y., Oh, M., Kim, E., & Choe, K. (2003) · Clinical Infectious Diseases · doi:10.1086/377200 · Cited by 565
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 556
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
The biological cost of mutational antibiotic resistance: any practical conclusions?
Andersson, D. I. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.07.002 · Cited by 472
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
Souli, M., Galani, I., & Giamarellou, H. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19045-en · Cited by 436
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Animal model pharmacokinetics and pharmacodynamics: a critical review
Andes, D., & Craig, W. A. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00022-5 · Cited by 413
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Michalopoulos, A. S., Livaditis, I. G., & Gougoutas, V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.07.007 · Cited by 378
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Nation, R. L., Li, J., Cars, O., Couet, W., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 354
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Role of Pseudomonas aeruginosa type III effectors in disease
Engel, J., & Balachandran, P. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.12.007 · Cited by 330
Lodise, T. P., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., & McGregor, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-07 · Cited by 318
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Nation, R. L., Velkov, T., & Li, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu213 · Cited by 310
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Self-citationMarkou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Haidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Forti, F., Roach, D. R., Cafora, M., Pasini, M. E., Horner, D. S., Fiscarelli, E. V., Rossitto, M., Cariani, L., Briani, F., Debarbieux, L., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02573-17 · Cited by 269
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility
Kos, V. N., Déraspe, M., McLaughlin, R. E., Whiteaker, J. D., Roy, P. H., Alm, R. A., Corbeil, J., & Gardner, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03954-14 · Cited by 264
Dosing guidance for intravenous colistin in critically-ill patients.
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw839 · Cited by 262
Wright, H., Bonomo, R. A., & Paterson, D. L. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.001 · Cited by 256
The Versatile Mutational Resistome of Pseudomonas aeruginosa
López-Causapé, C., Cabot, G., del Barrio-Tofiño, E., & Oliver, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00685 · Cited by 254
Self-citationLinden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
Self-citationDalfino, L., Puntillo, F., Mosca, A., Monno, R., Spada, M. L., Coppolecchia, S., Miragliotta, G., Bruno, F., & Brienza, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis286 · Cited by 247
Management of meningitis due to antibiotic-resistant Acinetobacter species
Kim, B.-N., Peleg, A. Y., Lodise, T. P., Lipman, J., Li, J., Nation, R., & Paterson, D. L. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70055-6 · Cited by 244
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Coleman, K. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.026 · Cited by 241
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Zavascki, A. P., & Nation, R. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02319-16 · Cited by 239
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01968-17 · Cited by 235
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Zusman, O., Avni, T., Leibovici, L., Adler, A., Friberg, L., Stergiopoulou, T., Carmeli, Y., & Paul, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-13 · Cited by 233
Diene, S. M., & Rolain, J.-M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12655 · Cited by 231
The Power of Asymmetry: Architecture and Assembly of the Gram-Negative Outer Membrane Lipid Bilayer
Henderson, J. C., Zimmerman, S. M., Crofts, A. A., Boll, J. M., Kuhns, L. G., Herrera, C. M., & Trent, M. S. (2016) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095308 · Cited by 231
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Cabot, G., Ocampo-Sosa, A. A., Domínguez, M. A., Gago, J. F., Juan, C., Tubau, F., Rodríguez, C., Moyà, B., Peña, C., Martínez-Martínez, L., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-12 · Cited by 227
Self-citationSorlí, L., Luque, S., Grau, S., Berenguer, N., Segura, C., Montero, M. M., Álvarez-Lerma, F., Knobel, H., Benito, N., & Horcajada, J. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-380 · Cited by 225
Self-citationNeidell, M. J., Cohen, B., Furuya, Y., Hill, J., Jeon, C. Y., Glied, S., & Larson, E. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis552 · Cited by 223
Pena, C., Cabot, G., Gomez-Zorrilla, S., Zamorano, L., Ocampo-Sosa, A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu866 · Cited by 216
Self-citationPetrosillo, N., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02061.x · Cited by 213
Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
Treepong, P., Kos, V. N., Guyeux, C., Blanc, D. S., Bertrand, X., Valot, B., & Hocquet, D. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.018 · Cited by 212
Castanheira, M., Deshpande, L. M., Costello, A., Davies, T. A., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku048 · Cited by 208
Cabot, G., Zamorano, L., Moyá, B., Juan, C., Navas, A., Blázquez, J., & Oliver, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02676-15 · Cited by 208
Self-citationLu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Fraile-Ribot, P. A., Cabot, G., Mulet, X., Periañez, L., Martín-Pena, M. L., Juan, C., Pérez, J. L., & Oliver, A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx424 · Cited by 207
Self-citationFarrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01802-13 · Cited by 203
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., & Falagas, M. E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.028 · Cited by 202
Blot, S., Vandewoude, K., De Bacquer, D., & Colardyn, F. (2002) · Clinical Infectious Diseases · doi:10.1086/340616 · Cited by 201
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Reina, R., Estenssoro, E., Sáenz, G., Canales, H. S., Gonzalvo, R., Vidal, G., Martins, G., Das Neves, A., Santander, O., & Ramos, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2691-4 · Cited by 186
Dai, C., Li, J., Tang, S., Li, J., & Xiao, X. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-14 · Cited by 185
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 177
Peña, C., Suarez, C., Gozalo, M., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., Calbo, E., Rodríguez‐Baño, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05991-11 · Cited by 175
Self-citationRiera, E., Cabot, G., Mulet, X., Garcia-Castillo, M., del Campo, R., Juan, C., Canton, R., & Oliver, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr232 · Cited by 175
Self-citationJuan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Self-citationTargeting virulence not viability in the search for future antibacterials
Heras, B., Scanlon, M. J., & Martin, J. L. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12356 · Cited by 174
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Juan, C., Peña, C., & Oliver, A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw299 · Cited by 170
Self-citationdel Barrio-Tofiño, E., López-Causapé, C., Cabot, G., Rivera, A., Benito, N., Segura, C., Montero, M. M., Sorlí, L., Tubau, F., Gómez-Zorrilla, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01589-17 · Cited by 170
Self-citationZusman, O., Altunin, S., Koppel, F., Dishon Benattar, Y., Gedik, H., & Paul, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw377 · Cited by 169
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation, R. L., Garonzik, S. M., Li, J., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Paterson, D. L., Turnidge, J. D., Forrest, A., & Silveira, F. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ964 · Cited by 168
Han, S., Zaniewski, R. P., Marr, E. S., Lacey, B. M., Tomaras, A. P., Evdokimov, A., Miller, J. R., & Shanmugasundaram, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013092107 · Cited by 166
Alvarez-Ortega, C., Wiegand, I., Olivares, J., Hancock, R. E. W., & Martínez, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00257-10 · Cited by 164
Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis
Zelenitsky, S. A., Harding, G. K. M., Sun, S., Ubhi, K., & Ariano, R. E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg403 · Cited by 163
Nichols, W. W., de Jonge, B. L. M., Kazmierczak, K. M., Karlowsky, J. A., & Sahm, D. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-16 · Cited by 163
New β-Lactamase Inhibitors in the Clinic
Papp-Wallace, K. M., & Bonomo, R. A. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.007 · Cited by 162
Bassetti, M., Castaldo, N., Cattelan, A., Mussini, C., Righi, E., Tascini, C., Menichetti, F., Mastroianni, C. M., Tumbarello, M., Grossi, P., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.001 · Cited by 162
Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 161
del Barrio-Tofiño, E., Zamorano, L., Cortés-Lara, S., López-Causapé, C., Sánchez-Diener, I., Cabot, G., Bou, G., Martínez-Martínez, L., Oliver, A., GEMARA-SEIMC/REIPI Pseudomonas study Group, et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz147 · Cited by 161
Self-citationLópez-Causapé, C., Sommer, L. M., Cabot, G., Rubio, R., Ocampo-Sosa, A. A., Johansen, H. K., Figuerola, J., Cantón, R., Kidd, T. J., Molin, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05621-5 · Cited by 158
Self-citationSkurnik, D., Roux, D., Cattoir, V., Danilchanka, O., Lü, X., Yoder-Himes, D. R., Han, K., Guillard, T., Jiang, D., Gaultier, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221552110 · Cited by 157
Xiao, A. J., Miller, B. W., Huntington, J. A., & Nicolau, D. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.566 · Cited by 157
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
Berlana, D., Llop, J. M., Casamartina, E. F., Badia, M., & Jódar, R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.1.39 · Cited by 155
Winkler, M., Papp‐Wallace, K. M., Hujer, A. M., Domitrovic, T., Hujer, K. M., Hurless, K. N., Tuohy, M. J., Hall, G. S., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04238-14 · Cited by 150
Sader, H. S., Farrell, D. J., Castanheira, M., Flamm, R. K., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku184 · Cited by 149
Lob, S. H., Hackel, M., Kazmierczak, K. M., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02209-16 · Cited by 149
Status report on carbapenemases: challenges and prospects
Patel, G., & Bonomo, R. A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.28 · Cited by 146
Rigatto, M. H., de Oliveira, M. S., Neto, L. V. P., Levin, A. S., Carrilho, C. M. D. D. M., Tanita, M. T., Tuon, F. F., Cardoso, D. E., Lopes, N. T., Falci, D. R., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-15 · Cited by 145
Bruchmann, S., Dötsch, A., Nouri, B., Chaberny, I. F., & Häußler, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-12 · Cited by 144
Cabot, G., López-Causapé, C., Ocampo-Sosa, A. A., Sommer, L. M., Domínguez, M. Á., Zamorano, L., Juan, C., Tubau, F., Rodríguez, C., Moyá, B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01720-16 · Cited by 144
Self-citationMunita, J. M., Aitken, S. L., Miller, W. R., Pérez, F., Rosa, R. M., Shimose, L. A., Lichtenberger, P. K., Abbo, L. M., Jain, R., Nigo, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix014 · Cited by 142
Craig, W. A., & Andes, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01590-12 · Cited by 138
Klevens, R. M., Edwards, J. R., Gaynes, R. P., & System, N. N. I. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591698 · Cited by 136
Gallagher, J. C., Satlin, M. J., Elabor, A., Saraiya, N., McCreary, E. K., Molnar, E., El‐Beyrouty, C., Jones, B. M., Dixit, D., Heil, E. L., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy280 · Cited by 136
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
Mulet, X., Cabot, G., Ocampo-Sosa, A. A., Domínguez, M. Á., Zamorano, L., Juan, C., Tubau, F., Rodríguez, C., Moyá, B., Peña, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01481-13 · Cited by 135
Self-citationDiaz Caballero, J., Clark, S. T., Coburn, B., Zhang, Y., Wang, P. W., Donaldson, S. L., Tullis, D. E., Yau, Y. C. W., Waters, V. J., Hwang, D. M., et al. (2015) · mBio · doi:10.1128/mbio.00981-15 · Cited by 132
Wood, T. L., & Wood, T. K. (2016) · MicrobiologyOpen · doi:10.1002/mbo3.346 · Cited by 132
Dötsch, A., Becker, T., Pommerenke, C., Magnowska, Z., Jänsch, L., & Häussler, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-09 · Cited by 131
Sader, H. S., Castanheira, M., Duncan, L. R., & Flamm, R. K. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.04.012 · Cited by 131
Pseudomonas aeruginosa Ventilator-associated Pneumonia. Predictive Factors of Treatment Failure
Planquette, B., Timsit, J.-F., Misset, B. Y., Schwebel, C., Azoulay, E., Adrie, C., Vesin, A., Jamali, S., Zahar, J.-R., Allaouchiche, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1897oc · Cited by 130
Bergen, P. J., Tsuji, B. T., Bulitta, J. B., Forrest, A., Jacob, J., Sidjabat, H. E., Paterson, D. L., Nation, R. L., & Li, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05298-11 · Cited by 128
Bergen, P. J., Forrest, A., Bulitta, J. B., Tsuji, B. T., Sidjabat, H. E., Paterson, D. L., Li, J., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05028-11 · Cited by 128
Paterson, D. L., & Rice, L. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374243 · Cited by 126
Ali, S. O., Yu, X. Q., Robbie, G. J., Wu, Y., Shoemaker, K., Yu, L., DiGiandomenico, A., Keller, A. E., Anude, C., Hernandez-Illas, M., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.004 · Cited by 124
Crandon, J. L., Schuck, V., Banevicius, M. A., Beaudoin, M., Nichols, W. W., Tanudra, M. A., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-12 · Cited by 121
Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*
El-Solh, A. A., Hattemer, A., Hauser, A. R., Alhajhusain, A., & Vora, H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182377906 · Cited by 120
Sader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 120
Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-13 · Cited by 119
Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K., Peng, L., Zha, J., Chowdury, P., Sellman, B., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 118
Sanz‐García, F., Hernando‐Amado, S., & Martínez, J. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01379-18 · Cited by 118
New insights into the antibacterial mechanism of action of squalamine
Alhanout, K., Malesinki, S., Vidal, N., Peyrot, V., Rolain, J., & Brunel, J. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq213 · Cited by 117
Olivares‐Pacheco, J., Alvarez‐Ortega, C., Alcalde‐Rico, M., & Martínez, J. L. (2017) · mBio · doi:10.1128/mbio.00500-17 · Cited by 116
Colistin pharmacokinetics: the fog is lifting
Couet, W. R., Grégoire, N., Marchand, S., & Mimoz, O. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03667.x · Cited by 111
Cholley, P., Thouverez, M., Hocquet, D., van der Mee-Marquet, N. L., Talon, D. R., & Bertrand, X. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00102-11 · Cited by 111
Polymyxins for CNS infections: Pharmacology and neurotoxicity
Velkov, T., Dai, C., Ciccotosto, G. D., Cappai, R., Hoyer, D., & Li, J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.012 · Cited by 111
Interaction of Avibactam with Class B Metallo-β-Lactamases
Abboud, M. I., Damblon, C., Brem, J., Smargiasso, N., Mercuri, P. S., Gilbert, B., Rydzik, A. M., Claridge, T. D. W., Schofield, C. J., & Frère, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00897-16 · Cited by 110
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 110
Matsumoto, S., Singley, C. M., Hoover, J. L., Nakamura, R., ECHOLS, R. M., Rittenhouse, S. F., Tsuji, M., & Yamano, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-17 · Cited by 108
Jain, R., Beckett, V. V., Konstan, M. W., Accurso, F. J., Burns, J. L., Mayer-Hamblett, N., Milla, C., VanDevanter, D. R., & Chmiel, J. F. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.12.006 · Cited by 108
Giani, T., Arena, F., Pollini, S., Pilato, V. D., D’Andrea, M. M., Angelis, L. H. D., Bassetti, M., Rossolini, G. M., Pseudomonas aeruginosa Working Group, Vismara, C. S., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx453 · Cited by 108
Hsueh, S.-C., Lee, Y., Huang, Y., Liao, C., Tsuji, M., & Hsueh, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky425 · Cited by 108
Viedma, E., Juan, C., Acosta, J., Zamorano, L., Otero, J. R., Sanz, F., Chaves, F., & Oliver, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00900-09 · Cited by 107
Self-citationPolymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells
Azad, M. A. K., Finnin, B. A., Poudyal, A., Davis, K., Li, J., Hill, P., Nation, R. L., Velkov, T., & Li, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02587-12 · Cited by 107
Vicari, G., Bauer, S. R., Neuner, E. A., & Lam, S. W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis909 · Cited by 107
CrpP Is a Novel Ciprofloxacin-Modifying Enzyme Encoded by the Pseudomonas aeruginosa pUM505 Plasmid
Chávez-Jacobo, V. M., Hernández-Ramírez, K. C., Romo-Rodríguez, P., Pérez‐Gallardo, R. V., Campos‐García, J., Gutiérrez-Corona, J. F., García-Merinos, J. P., Carmen, V. M., Silva-Sánchez, J., & Ramírez-Díaz, M. I. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02629-17 · Cited by 107
Li, J., Lovern, M., GREEN, M. L., Chiu, J., Zhou, D., Comisar, C. M., Xiong, Y., Hing, J. P., Macpherson, M. P., Wright, J. G., et al. (2018) · Clinical and Translational Science · doi:10.1111/cts.12585 · Cited by 105
Furtado, G. H. C., d’Azevedo, P. A., Santos, A. F., Gales, A. C., Pignatari, A. C. C., & Medeiros, E. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.017 · Cited by 104
Hocquet, D., Berthelot, P., Roussel‐Delvallez, M., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00503-07 · Cited by 102
Lang, A. B., Rüdeberg, A., Schöni, M. H., Que, J. U., Fürer, E., & Schaad, U. B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129688.50588.ac · Cited by 101
Koulenti, D., Song, A., Ellingboe, A., Abdul-Aziz, M. H., Harris, P. N. A., Gavey, E., & Lipman, J. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.10.011 · Cited by 101
Ferry, T., Boucher, F., Fèvre, C., Perpoint, T., Château, J., Petitjean, C., Josse, J., Chidiac, C., L’Hostis, G., Leboucher, G., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky263 · Cited by 100
Juan, C., Torrens, G., González-Nicolau, M., & Oliver, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux043 · Cited by 99
Self-citationPfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Chang, R. Y. K., Chen, K., Wang, J., Wallin, M., Britton, W. J., Morales, S., Kutter, E. M., Li, J., & Chan, H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01714-17 · Cited by 96
Montero, M., Horcajada, J. P., Sorlí, L., et al. (2009) · Infection · doi:10.1007/s15010-009-8342-x · Cited by 95
Self-citationBuehrle, D. J., Shields, R. K., Chen, L., Hao, B., Press, E. G., Alkrouk, A., Potoski, B. A., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02969-15 · Cited by 95
Park, S.-Y., Park, H. J., Moon, S. M., Park, K.-H., Chong, Y. P., Kim, M.-N., Kim, S.-H., Lee, S.-O., Kim, Y. S., Woo, J. H., et al. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-308 · Cited by 91
Bolard, A., Plésiat, P., & Jeannot, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01835-17 · Cited by 90
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Martínez, O. F., Rigueiras, P. O., Pires, Á. D. S., Porto, W. F., Silva, O. N., de la Fuente‐Núñez, C., & Franco, O. L. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00444 · Cited by 88
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
From DNA to FBA: How to Build Your Own Genome-Scale Metabolic Model
Cuevas, D., Edirisinghe, J. N., Henry, C., Overbeek, R., O’Connell, T., & Edwards, R. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00907 · Cited by 83
Tabor, D. E., Oganesyan, V., Keller, A. E., Yu, L., McLaughlin, R. E., Song, E., Warrener, P., Rosenthal, K., Esser, M. T., Qi, Y., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy438 · Cited by 82
Pereira, G. H., Müller, P. R., & Levin, A. S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.008 · Cited by 81
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
Skiada, A., Markogiannakis, A., Plachouras, D., & Daikos, G. L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.019 · Cited by 80
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Rello, J., Krenn, C.-G., Locker, G., Pilger, E., Madl, C., Balica, L., Dugernier, T., Laterre, P.-F., Spapen, H., Depuydt, P., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1601-9 · Cited by 80
Witney, A. A., Gould, K. A., Pope, C. F., Bolt, F., Stoker, N. G., Cubbon, M., Bradley, C. R., Fraise, A. P., Breathnach, A. S., Butcher, P. D., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12528 · Cited by 79
Sader, H. S., Castanheira, M., Huband, M. D., Jones, R. N., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-17 · Cited by 79
Gómez-Zorrilla, S., Camoez, M., Tubau, F., Cañizares, R., Periche, E., Domínguez, M. Á., Ariza, J., & Peña, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04636-14 · Cited by 78
Self-citationSuárez, C., Peña, C., Gavaldà, L., Tubau, F., Manzur, A., Domínguez, M. Á., Pujol, M., Gudiol, F., & Ariza, J. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.11.019 · Cited by 77
Stone, G. G., Newell, P., Gasink, L. B., Broadhurst, H., Wardman, A., Yates, K., Chen, Z., Song, J., & Chow, J. W. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky204 · Cited by 77
Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa
Jaillard, M., van Belkum, A., Cady, K. C., Creely, D., Shortridge, D., Blanc, B., Barbu, E. M., Dunne, W. M., Zambardi, G., Enright, M. C., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.026 · Cited by 76
Forrest, A., Merali, S. J., Thamlikitkul, V., Giamarellos‐Bourboulis, E. J., Paterson, D. L., Li, J., Silveira, F. P., & Nation, R. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01367-17 · Cited by 76
Cañestro, M. D., Periañez, L., Mulet, X., Martín-Pena, M. L., Fraile-Ribot, P. A., Ayestarán, I., Colomar, A., Núñez, B., Macia, M. D., Novo, A., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3361-0 · Cited by 76
Self-citationPeña, C., Gómez-Zorrilla, S., Oriol, I., Tubau, F., Domínguez, M. Á., Pujol, M., & Ariza, J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1758-8 · Cited by 75
Self-citationOng, C. T., Tessier, P. R., Li, C., Nightingale, C. H., & Nicolau, D. P. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.06.014 · Cited by 75
Feng, Y., Jonker, M. J., Moustakas, I., Brul, S., & ter Kuile, B. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00434-16 · Cited by 74
Lin, Y.-W., Zhou, Q. T., Onufrak, N. J., Wirth, V., Chen, K., Wang, J., Forrest, A., Chan, H., & Li, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00211-17 · Cited by 74
The Therapeutic Pipeline for Pseudomonas aeruginosa Infections
Burrows, L. L. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00112 · Cited by 74
Ito, A., Nishikawa, T., Oota, M., Ito-Horiyama, T., Ishibashi, N., Sato, T., Tsuji, M., & Yamano, Y. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky317 · Cited by 74
New promising β-lactamase inhibitors for clinical use
Olsen, I. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2375-0 · Cited by 73
In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics
Melchior, N. H., & Keiding, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.29 · Cited by 71
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1
Drusano, G. L., Louie, A., MacGowan, A. P., & Hope, W. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02177-15 · Cited by 71
Characteristic of Bacteriocines and Their Application
KARPIŃSKI, T. M., & SZKARADKIEWICZ, A. K. (2013) · Polish Journal of Microbiology · doi:10.33073/pjm-2013-030 · Cited by 70
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Reboud, E., Elsen, S., Bouillot, S., Golovkine, G. R., Basso, P., Jeannot, K., Attrée, I., & Huber, P. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13262 · Cited by 70
Horcajada, J. P., Sorlí, L., Luque, S., Benito, N., Segura, C., Campillo, N., Montero, M., Esteve, E., Mirelis, B., Pomar, V., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.020 · Cited by 70
Self-citationAsuphon, O., Montakantikul, P., Houngsaitong, J., Kiratisin, P., & Sonthisombat, P. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.017 · Cited by 69
Maraolo, A. E., Cascella, M., Corcione, S., Cuomo, A., Nappa, S., Borgia, G., Rosa, F. G. D., & Gentile, I. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1367666 · Cited by 69
Rigatto, M. H., Vieira, F. J., Antochevis, L. C., Behle, T. F., Lopes, N. T., & Zavascki, A. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00494-15 · Cited by 68
Sader, H. S., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02083-16 · Cited by 68
Turton, J. F., Wright, L. L., Underwood, A. P., Witney, A. A., Chan, Y.-T., Al‐Shahib, A., Arnold, C. E., Doumith, M., Patel, B., Planche, T., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00505-15 · Cited by 65
Recio, R., Villa, J., Viedma, E., Orellana, M. Á., Lora‐Tamayo, J., & Cháves, F. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.03.018 · Cited by 65
Spread of Carbapenem Resistance by Transposition and Conjugation Among Pseudomonas aeruginosa
van der Zee, A., Kraak, B., Burggraaf, A., Goessens, W. H. F., Pirovano, W., Ossewaarde, J. M., & Tommassen, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02057 · Cited by 64
Cited by
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106196 · Cited by 372
Self-citationElfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Metadata
- Authors
- Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2019-09-18
- Volume
- 32
- Issue
- 4
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2970103499
- Cited by
- 961
- References
- 273
- FWCI
- 25.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.